Genelux (GNLX) Profit After Tax (2022 - 2026)

Genelux (GNLX) recorded quarterly Profit After Tax of -$8.9 million in Q1 2026, up 2.96% quarter-over-quarter from -$9.2 million in Q4 2025, and down 19.17% on a YoY basis from -$11.0 million in Q1 2025.

Genelux (GNLX) Profit After Tax (2022 - 2026) Analysis & Trends

Genelux's Profit After Tax history runs 5 years deep, the most recent figure standing at -$8.9 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 19.17% year-over-year to -$8.9 million; the TTM figure through Mar 2026 stood at -$33.5 million (down 13.63% YoY), while the FY2025 annual figure was -$32.1 million, down 7.47% from the prior year.
  • Profit After Tax was -$8.9 million for Q1 2026 at Genelux, up from -$9.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $4.9 million in Q3 2022 to a low of -$10.4 million in Q1 2023.
  • Historically, Profit After Tax has averaged -$6.5 million across 5 years, with a median of -$7.5 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Profit After Tax plunged 208.88% in 2023, then gained 24.26% in 2024.
  • A 5-year view of Profit After Tax shows it stood at -$3.5 million in 2022, then tumbled by 93.62% to -$6.8 million in 2023, then slumped by 32.64% to -$9.0 million in 2024, then declined by 2.5% to -$9.2 million in 2025, then gained by 2.96% to -$8.9 million in 2026.
  • The last three Profit After Tax figures came in at -$8.9 million (Q1 2026), -$9.2 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.90 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.63 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -753,254.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.74 Mn
10 Genelux 129.36 Mn 129.36 Mn - -8.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.93 Mn
Dec 31, 2025 -9.20 Mn
Sep 30, 2025 -7.95 Mn
Jun 30, 2025 -7.46 Mn
Mar 31, 2025 -7.49 Mn
Dec 31, 2024 -8.98 Mn
Sep 30, 2024 -6.47 Mn
Jun 30, 2024 -6.58 Mn
Mar 31, 2024 -7.85 Mn
Dec 31, 2023 -6.77 Mn
Sep 30, 2023 -5.35 Mn
Jun 30, 2023 -5.82 Mn
Mar 31, 2023 -10.36 Mn
Dec 31, 2022 -3.50 Mn
Sep 30, 2022 4.91 Mn